FcRIIB mediates C-reactive protein inhibition of endothelial NO synthase
Mineo C, Gormley AK, Yuhanna IS, Osborne-Lawrence S, Gibson LL, Hahner L, Shohet RV, Black S, Salmon JE, Samols D, Karp DR, Thomas GD, Shaul PW. FcRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res. 2005;97:1124-1131.
Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis. Concomitant suppression of the expression of dendritic cells
Shioji K, Kishimoto C, Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis. Concomitant suppression of the expression of dendritic cells. Circ Res. 2001;89:540-546.
Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion
Yuan Z, Kishimoto C, Sano H, Shioji K, Xu Y, Yokode M. Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. Am J Physiol Heart Circ Physiol. 2003;285:H899-H906.
Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin
Gill V, Doig C, Knight D, Love E, Kubes P. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation. 2005;112:2031-2039.
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
Native C-reactive protein increases whereas modified c-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice
Schwedler SB, Amann K, Wemicke K, Krebs A, Nauck M, Wanner C, Potempa LA, and Galle J. Native C-reactive protein increases whereas modified c-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2005;112:1016-1023.
